Pharmacokinetics of a degradable drug delivery system in bone

Clinical Orthopaedics and Related Research

Volumn 349, Issue , 1998, Pages 218-224

  Humphrey, J Stewart ^a   Mehta, Sanjay ^a   Seaber, Anthony V ^a   Vail, Thomas Parker ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; INOCOLL; UNCLASSIFIED DRUG;

ACHILLES TENDON; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BONE; CATTLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG URINE LEVEL; FEMUR; INTRAOSSEOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPONGE;

EID: 0031956978     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199804000-00027     Document Type: Article

References (14)

1. Buchholz HW, Gartmann HD: Infektionsprophylaxe und operative behandlung der schleichenden tiefen infektion bei der totalen endoprothese. Chirug 43:446-453, 1972.
2. Cornell CN, Tyndall D, Waller S, Lane JM, Brause BD: Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute. J Orthop Res 12:619-626, 1993.
3. Curl JL, Curl JS: Pharmacokinetics of gentamicin in laboratory rabbits. Am J Vet Res 49:2065-2067, 1988.
4. Elliot J, Setterstrom JA, Durwood EB, et al: Evaluation of biodegradable ampicillin anhydrate micro-capsules for local treatment of experimental staphylococcal osteomyelitis. Clin Orthop 267: 237-244, 1991.
5. Grimm H: Bacteriological and Pharmacokinetic Aspects of Locally Applied Antibiotics. In Stemberger A, Ascherl R, Lechner F, Blumel G (eds). Collagen as a Drug Carrier: Some Applications in Surgery. Munich, Franklin Scientific 27-30, 1991.
6. Jolley ME, Stroupe SD, Wang CH, et al: Fluorescence polarization immunoassay: Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem 27:1190-1197, 1945.
7. Klemm KW: Gentamicin PMMA chains (Septopal® Chains) for the local antibiotic treatment of chronic osteomyelitis. Reconstr Surg Traumat 20:11-35, 1988.
8. Korkusuz F, Uchida A, Shinto Y, et al: Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J Bone Joint Surg 75B:111-114, 1993.
9. Mehta S, Humphrey JS, Schenkman DL, Seaber AV, Vail TP: Gentamicin distribution from a collagen carrier. J Orthop Res 14:749-754, 1996.
10. Miclau T, Dahners LE, Lindsey RW. In vitro pharmacokinetics of antibiotic release from locally implantable material. J Orthop Res 11:627-632, 1993.
11. Noone P, Parsons TMC, Pattison JR, et al: Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J 1:477-481, 1974.
12. Sasmor MT, Morain WD, Balestrero LM, Camp BJ: Investigation of a biodegradable, implantable antibiotic delivery system on rate of wound infection. Ann Plast Surg 30:525-530, 1993.
13. Trelstad RL: Methods of Collagen Fractionation. In Furthmayr H (ed). Immunochemistry of the Extracellular Matrix. Vol 1. Boca Raton, CRC 31-42, 1982.
14. Zaske DE, Shikuma LR, Tholl DA: Aminoglycosides. In Taylor WJ, Cavines MHD (eds). A Textbook for the Clinical Application of Therapeutic Drug Monitoring. Irving, Texas, Abbott Laboratories 285-320, 1986.